RESUMO
Understanding how the hippocampus processes episodic memory information during neuropathological conditions is important for treatment and prevention applications. Previous data have shown that during chronic neuroinflammation the expression of the plasticity related behaviourally-induced immediate early gene Arc is altered within the CA3 and the dentate gyrus; both of these hippocampal regions show a pronounced increase in activated microglia. Low doses of memantine, a low to moderate affinity open channel uncompetitive N-Methyl-d-aspartate receptor antagonist, reduce neuroinflammation, return Arc expression to control levels and attenuate cognitive deficits induced by lipopolysaccharide. Here we investigate whether neuroinflammation affects the accuracy of information processing in the CA3 and CA1 hippocampal regions and if this is modified by memantine treatment. Using the immediate early gene-based brain-imaging method called cellular analysis of temporal activity by fluorescence in situ hybridization, it is possible to detect primary transcripts at the genomic alleles; this provides exceptional temporal and cellular resolution and facilitates the mapping of neuronal activity. Here, we use this method to compare the neuronal populations activated by two separate experiences in CA1 and CA3 and evaluate the accuracy of information processing during chronic neuroinflammation. Our results show that the CA3 pyramidal neuron activity is not stable between two exposures to the same environment context or two different contexts. CA1 networks, however, do not differ from control conditions. These data suggest that during chronic neuroinflammation, the CA3 networks show a disrupted ability to encode spatial information, and that CA1 neurons can work independently of CA3. Importantly, memantine treatment is able to partially normalize information processing in the hippocampus, suggesting that when given early during the development of the pathology memantine confers neuronal and cognitive protection while indirectly prevents pathological microglial activation.
Assuntos
Antagonistas de Aminoácidos Excitatórios/uso terapêutico , Hipocampo/fisiopatologia , Memantina/uso terapêutico , Inflamação Neurogênica/fisiopatologia , Animais , Mapeamento Encefálico/métodos , Células Cultivadas , Doença Crônica , Proteínas do Citoesqueleto/biossíntese , Proteínas do Citoesqueleto/genética , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos/métodos , Antagonistas de Aminoácidos Excitatórios/farmacologia , Comportamento Exploratório/efeitos dos fármacos , Comportamento Exploratório/fisiologia , Expressão Gênica , Genes Precoces , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Hibridização in Situ Fluorescente , Lipopolissacarídeos , Masculino , Memantina/farmacologia , Microglia/efeitos dos fármacos , Rede Nervosa/fisiopatologia , Proteínas do Tecido Nervoso/biossíntese , Proteínas do Tecido Nervoso/genética , Inflamação Neurogênica/tratamento farmacológico , Inflamação Neurogênica/psicologia , Neurônios/metabolismo , RNA Mensageiro/genética , Ratos , Ratos Endogâmicos F344 , Receptores de N-Metil-D-Aspartato/antagonistas & inibidoresRESUMO
The regimen of estrogen replacement can alter the consequences of estrogen therapy and stressors. To determine the long-term effects and interaction of these systems on the brain and periphery, adult female rats were infused with lipopolysaccharide (LPS) into the fourth ventricle of the brain for 4 weeks, and ovariectomized rats were administered either constant or pulsed regimens of estrogen replacement (17beta-estradiol) until sacrifice at 8 weeks. Constant, but not pulsed, estrogen replacement reduced ERalpha and increased HSP90, HSP70, and PR(B) uterine protein levels. Both estrogen regimens increased ERbeta, HSP27, and PR(A) uterine proteins. Both regimens reduced hypothalamic levels of ERalpha, but not ERbeta, HSP, or PR. No changes were observed in the hippocampus. Long-term brain infusion of LPS activated microglia and reduced body weight, but did not alter corticosterone or nitrotyrosine levels. LPS infusion into intact rats suppressed uterine weight, increased ERalpha and decreased HSP90 in the uterus. LPS did not alter uterine weight in ovariectomized rats treated with constant or pulsed estrogen. Together, these data suggest the timing of estrogen replacement and neuroinflammatory stressors can profoundly affect uterine and hypothalamic steroid receptor expression and may be important parameters to consider in the post-menopausal intervention with estrogen.
Assuntos
Encéfalo/efeitos dos fármacos , Terapia de Reposição de Estrogênios , Hipotálamo/metabolismo , Lipopolissacarídeos/farmacologia , Receptores de Estrogênio/metabolismo , Receptores de Progesterona/metabolismo , Útero/metabolismo , Animais , Estradiol/farmacologia , Receptor alfa de Estrogênio/metabolismo , Receptor beta de Estrogênio/metabolismo , Feminino , Proteínas de Choque Térmico/metabolismo , Injeções Intraventriculares , Lipopolissacarídeos/administração & dosagem , Ratos , Ratos Endogâmicos F344RESUMO
OBJECTIVE: Measures of cholinergic transmitter activity were investigated in patients with autism because of reported neuropathological abnormalities in cholinergic nuclei in the basal forebrain. METHOD: Levels of cholinergic enzyme and receptor activity were measured in the frontal and parietal cerebral cortex of deceased autistic adults, similarly aged normal adults without mental retardation, and nonautistic mentally retarded adults. The immunoreactivity levels of brain-derived neurotrophic factor and nerve growth factor were measured in the basal forebrain. RESULTS: There were no differences between the autistic and comparison groups in choline acetyltransferase or acetylcholinesterase activity in the cerebral cortex and basal forebrain or in muscarinic M(2) receptor or alpha-bungarotoxin binding within the cortex. Cortical M(1) receptor binding was up to 30% lower than normal in the autistic subjects, and the difference reached significance in the parietal cortex. In both the parietal and frontal cortices, differences in nicotinic receptors assessed by [(3)H]epibatidine binding were significant and extensive (65%-73% lower in the autistic group than in the normal subjects); there were no differences in nicotine binding in the basal forebrain. Immunochemical analysis indicated lower levels of both the alpha(4) and beta(2) nicotinic receptor subunits in the parietal cortex. The M(1) receptor abnormality was not evident in the nonautistic group with mental retardation, although the lower [(3)H]epibatidine binding was apparent. In the basal forebrain, the level of brain-derived neurotrophic factor in the autistic group was three times as high as the level of the normal group. CONCLUSIONS: These neurochemical abnormalities implicate the cholinergic system in developmental disorders such as autism and suggest the potential for intervention based on cholinergic receptor modulation.
Assuntos
Acetilcolinesterase/análise , Transtorno Autístico/diagnóstico , Córtex Cerebral/química , Córtex Cerebral/enzimologia , Colina O-Acetiltransferase/análise , Prosencéfalo/química , Prosencéfalo/enzimologia , Receptores Colinérgicos/análise , Acetilcolinesterase/metabolismo , Adulto , Transtorno Autístico/metabolismo , Autorradiografia/métodos , Biomarcadores , Colina O-Acetiltransferase/metabolismo , Síndrome de Down/diagnóstico , Síndrome de Down/metabolismo , Lobo Frontal/química , Lobo Frontal/metabolismo , Humanos , Deficiência Intelectual/diagnóstico , Deficiência Intelectual/metabolismo , Nicotina/metabolismo , Ácidos Nipecóticos/análise , Ácidos Nipecóticos/metabolismo , Lobo Parietal/química , Lobo Parietal/metabolismo , Piperazinas/análise , Piperazinas/metabolismo , Receptores Colinérgicos/metabolismo , Receptores Muscarínicos/análise , Receptores Muscarínicos/metabolismo , Receptores Nicotínicos/análiseRESUMO
Inflammatory processes may play a critical role in the degeneration of basal forebrain cholinergic cells that underlies some of the cognitive impairments associated with Alzheimer's disease. In the present study, the proinflammagen lipopolysaccharide, from the cell wall of Gram-negative bacteria, was used to produce inflammation within the basal forebrain of rats. The effects of acute, high-dose injections of lipopolysaccharide (2, 20 or 40 microg) upon basal forebrain chemistry and neuronal integrity were compared with the effects of chronic, low-dose lipopolysaccharide infusions (0.18, 0.25, 1.8 or 5.0 microg/h) for either 14, 37, 74 or 112 days. Acute exposure to lipopolysaccharide decreased cortical choline acetyltransferase activity and the number of immunoreactive choline acetyltransferase-positive cells within a small region of the basal forebrain. Regional levels of five different neuropeptides were unchanged by acute, high-dose lipopolysaccharide injections. Chronic lipopolysaccharide infusions produced (i) a time-dependent, but not dose-dependent, decrease in cortical choline acetyltransferase activity that paralleled a decline in the number of choline acetyltransferase- and p75-immunoreactive cells within the basal forebrain, and (ii) a dense distribution of reactive astrocytes and microglia within the basal forebrain. Chronic neuroinflammation might underlie the genesis of some neuropathological changes associated with normal ageing or Alzheimer's disease.
Assuntos
Colina O-Acetiltransferase/metabolismo , Inflamação/metabolismo , Inflamação/patologia , Neuropeptídeos/metabolismo , Prosencéfalo/metabolismo , Prosencéfalo/patologia , Doença Aguda , Animais , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Córtex Cerebral/patologia , Doença Crônica , Escherichia coli , Galanina/metabolismo , Lipopolissacarídeos/toxicidade , Masculino , Neurocinina B/metabolismo , Neuropeptídeo Y/metabolismo , Neurotensina/metabolismo , Prosencéfalo/efeitos dos fármacos , Ratos , Ratos Endogâmicos F344 , Somatostatina/metabolismo , Fatores de TempoRESUMO
The decline in choline acetyltransferase activity has been identified previously within the brains of patients with Rett syndrome and Alzheimer's disease. The level of [3H]vesamicol binding to a terminal vesicular acetylcholine transporter is inversely related to the decline in cortical choline acetyltransferase activity in Alzheimer's disease, which may be due to compensatory processes within surviving cholinergic terminals. In order to investigate whether similar cholinergic compensatory processes are present in the Rett syndrome brain and are altered by normal aging, we investigated the density of cholinergic vesicular transporters in (i) the brains of Rett syndrome patients, and (ii) young and old rats with experimentally-induced cholinergic cell loss. In Rett syndrome, a significant decline in choline acetyltransferase activity within the putamen and thalamus was directly correlated with a decline in [3H]vesamicol binding. In both young and old rats, basal forebrain lesions decreased cortical choline acetyltransferase activity significantly, while [3H]vesamicol binding was unchanged. In contrast to young and old lesioned rats and patients with Alzheimer's disease, cholinergic cells in the brains of patients with Rett syndrome do not compensate for the loss of cholinergic cells by increasing acetylcholine vesicular storage.
Assuntos
Gânglios da Base/fisiologia , Colina O-Acetiltransferase/metabolismo , Fármacos Neuromusculares Despolarizantes/metabolismo , Piperidinas/metabolismo , Síndrome de Rett/metabolismo , Acetilcolina/metabolismo , Adolescente , Adulto , Envelhecimento/fisiologia , Animais , Gânglios da Base/enzimologia , Gânglios da Base/metabolismo , Córtex Cerebral/enzimologia , Córtex Cerebral/crescimento & desenvolvimento , Córtex Cerebral/metabolismo , Criança , Pré-Escolar , Agonistas de Aminoácidos Excitatórios/farmacologia , Feminino , Humanos , Putamen/enzimologia , Putamen/crescimento & desenvolvimento , Putamen/metabolismo , Ratos , Ratos Endogâmicos F344 , Síndrome de Rett/enzimologia , Tálamo/enzimologia , Tálamo/crescimento & desenvolvimento , Tálamo/metabolismo , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiônico/farmacologiaRESUMO
In the southern districts of the GDR the calculated iodine uptake of adults was 80 micrograms/day before the iodine supplementation of the mixtures of mineral substances and the packet kitchen salt. The iodine supplementation of the mixtures of mineral substances for cattle and pig tripled the iodine content of the milk or increased it fivefold in the county of Erfurt and doubled the proportion of iodine of the meat, the inner parts and the sausage produced from them. In a daily consumption of 0.31 of milk and 250 g of meat and sausage a surplus supply of 35 micrograms of iodine for adults was calculated in the southern counties of the GDR. The 35 micrograms of iodine for the future necessary for covering the demand of iodine are certainly delivered by the iodized kitchen salt.
Assuntos
Ração Animal , Bovinos , Bócio Endêmico/prevenção & controle , Iodo/administração & dosagem , Suínos , Animais , Alemanha Oriental , Humanos , Iodo/deficiência , Carne/análise , Produtos da Carne/análise , Leite/análise , Necessidades Nutricionais , Fatores de RiscoRESUMO
The brain mechanisms involved in attention and memory were examined by testing rats in temporal discriminations designed to emphasize these cognitive processes. Normal rats were able to time each of two stimuli whether they were presented alone or together. Rats with lesions of the frontal cortex (FC) or nucleus basalis magnocellularis (NBM) were able to time each stimulus when it was presented alone, but not when it was presented together with another stimulus. Rather, these rats timed only the intruding stimulus and ignored the other, demonstrating a failure of divided attention. Rats with lesions of the fimbria-fornix (FF) or medial septal area (MSA) performed the divided attention task normally, but failed to remember the duration of a stimulus that had been terminated temporarily earlier in the trial, demonstrating a failure of working memory. These results provide another informative dissociation between the functions of the frontal and hippocampal systems, emphasizing frontal involvement in attention, and hippocampal involvement in working memory.
Assuntos
Atenção/fisiologia , Lobo Frontal/fisiologia , Percepção do Tempo/fisiologia , Animais , Gânglios da Base/fisiologia , Comportamento Animal/fisiologia , Encéfalo/enzimologia , Colina O-Acetiltransferase/metabolismo , Condicionamento Psicológico , Septo Pelúcido/fisiologiaRESUMO
The response of the serotonergic system following injury to the basal forebrain cholinergic system was investigated in rats. The density of 5-hydroxytryptamine (serotonin) type 2 (S2) receptor sites in the frontal cortex and hippocampus was determined 1 week and 4 months after production of lesions by injections of ibotenic acid into the medial septum and nucleus basalis magnocellularis. One week later, the number of S2 receptor sites in the frontal neocortex, as defined by [3H]ketanserin binding, was unchanged. Four months later, the number of [3H]ketanserin binding sites (and Bmax) was increased and high-affinity [3H]serotonin uptake was decreased in the frontal neocortex, but not in the hippocampus, relative to unlesioned controls. Choline acetyltransferase (acetyl-CoA:choline O-acetyltransferase; EC 2.3.1.6) activity was decreased significantly in the frontal neocortex and hippocampus 1 week and 4 months after surgery. The change in frontal neocortical S2 receptor site density was inversely related to the level of choline acetyltransferase activity, was specific for cholinergic denervation associated with the cortex but not the hippocampus, and may represent a localized denervation supersensitivity due to degeneration of median raphe cortical afferents.
Assuntos
Córtex Cerebral/metabolismo , Diencéfalo/fisiologia , Ácido Ibotênico/farmacologia , Oxazóis/farmacologia , Piperidinas/metabolismo , Receptores de Serotonina/metabolismo , Telencéfalo/fisiologia , Animais , Colina O-Acetiltransferase/metabolismo , Diencéfalo/efeitos dos fármacos , Lobo Frontal/metabolismo , Hipocampo/metabolismo , Ketanserina , Masculino , Ratos , Ratos Endogâmicos , Telencéfalo/efeitos dos fármacosRESUMO
The functional contribution of the nucleus basalis magnocellularis (NBM) and medial septal area (MSA) to memory was evaluated in 4 behavioral tasks. The tasks were postoperative acquisition of a win-stay spatial discrimination in a T-maze, a win-shift spatial discrimination on a radial arm maze, active avoidance in a shuttle box, and passive avoidance in a shuttle box. Bilateral lesions were made by injecting ibotenic acid (IBO) into the NBM or MSA. Control rats received operations in which no neurotoxin was injected. When compared to controls, rats with lesions in either the NBM or MSA had significantly impaired choice accuracy in the T-maze and radial maze tasks, took significantly fewer trials to reach criterion in the acquisition, but not the retention of an active avoidance task, and significantly more trials to reach criterion in the passive avoidance task. The results show that equivalent behavioral changes are obtained from lesions in the NBM and MSA in tasks that vary in their type of motivation, reinforcement, response-reinforcement contingency, and response. These behavioral changes suggest that the NBM and MSA may both be involved in memory.
Assuntos
Gânglios da Base/fisiologia , Lobo Frontal/fisiologia , Sistema Límbico/fisiologia , Memória/fisiologia , Substância Inominada/fisiologia , Animais , Mapeamento Encefálico , Colina O-Acetiltransferase/metabolismo , Fibras Colinérgicas/fisiologia , Hipocampo/fisiologia , Masculino , Motivação/fisiologia , Vias Neurais/fisiologia , Ratos , Septo Pelúcido/fisiologiaRESUMO
The brindled mutant mouse is a useful model to study Menkes kinky-hair syndrome. The metabolic dysfunctions in both human and rodent are related to insufficient levels of bioavailable copper. Recently, copper supplementation therapy has been able both to prevent the appearance of various neuropathological changes and to prolong the life of these mutant mice. The optimum conditions for supplementation have been shown to be two intraperitoneal injections on postnatal days 7 and 10. The present study reports on the brain copper concentrations before, during and after the intraperitoneal copper therapy. The results demonstrate that postnatal days 7 and 10 correspond to two important epochs in copper homoeostasis. The supplementation therapy seems to provide sufficient bioavailable copper to respond to the needs of the animal at these crucial time points. The results are discussed in terms of their importance to the human copper disorder.